Invivyd (IVVD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Voting matters and shareholder proposals
Six nominees are up for election to the board of directors for a one-year term expiring at the 2027 annual meeting.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is proposed.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
The board consists of six nominees: Tamsin Berry, Paul B. Bolno, M.D., Marc Elia, Terrance McGuire, Kevin F. McLaughlin, and Ajay Royan.
Directors are elected for one-year terms, with annual elections.
Audit committee and external auditor matters
PricewaterhouseCoopers LLP is recommended for ratification as the independent auditor for the 2026 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Invivyd
- Q2 2026 revenue grew 21% but net loss widened, with future revenue at risk from PEMGARDA EUA expiry.IVVD
Q2 2026 - VYD2311 advances toward late-stage COVID-19 prevention, with broad pipeline and market ambitions.IVVD
H.C. Wainwright “HCW @ Home” Series - Antibody-based prevention aims to surpass vaccines in protection, safety, and patient preference.IVVD
Jefferies Global Healthcare Conference 2026 - Directors were elected and the auditor ratified, with no additional proposals or questions.IVVD
AGM 2026 - PEMGARDA revenue up 22% YoY to $13.7M; net loss $41.4M; VYD2311 trial on track for Q3 data.IVVD
Q1 2026 - VYD2311 and VMS063 advance in pivotal COVID-19 and measles studies, targeting urgent unmet needs.IVVD
Study update - Q3 revenue up 41% YoY to $13.1M, net loss narrowed, and pivotal VYD2311 trials set for year-end.IVVD
Q3 2025 - VYD2311 aims for durable, safe COVID protection with strong efficacy in pivotal prevention trials.IVVD
Study Update - Q2 PEMGARDA launch drove $2.3M revenue, but cash runway is under one year.IVVD
Q2 2024